Wednesday, June 28, 2017 8:26:33 AM
Nothing special still in phase1/2 read news still got a long way to go
D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.
Recent CBIO News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:18:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:16:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:15:24 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 03/27/2026 08:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/17/2026 08:00:35 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 03/06/2026 09:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/04/2026 05:15:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/26/2026 02:04:21 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 12:32:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:30:15 PM
- Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/26/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:27:21 PM
- Crescent Biopharma to Present at March Investor Conferences • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 02/19/2026 12:30:00 PM
- Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors • GlobeNewswire Inc. • 02/18/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/05/2026 12:30:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 01/30/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/15/2026 10:04:57 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/07/2026 10:08:21 PM
- Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Crescent Biopharma Announces Grants of Inducement Awards • GlobeNewswire Inc. • 12/18/2025 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 09:49:10 PM
